Airborne Ventures

Cover Block

PUBLIC

Attribute	Value
Name	Airborne Ventures
Tagline	A Brazil/LatAm-focused early-stage venture capital fund backing B2B fintech and healthcare startups.
Headquarters	São Paulo, Brazil
Founded	2021
Stage	Seed
Business Model	B2B
Industry	Fintech
Technology Type	Software (Non-AI)
Geography	Latin America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Links

PUBLIC

• Website: https://www.airborne.ventures/
• LinkedIn: https://br.linkedin.com/in/eduardokupper

Note: The provided LinkedIn link is for Founding Partner Eduardo Küpper; a dedicated company page for Airborne Ventures was not identified in the captured sources.

Executive Summary

PUBLIC Airborne Ventures is a São Paulo-based venture capital fund targeting early-stage B2B fintech and healthcare startups in Latin America, a region where specialized, hands-on capital remains a relative scarcity despite growing deal flow [Perplexity Sonar Pro Brief, retrieved 2024]. The firm, founded in 2021 by Eduardo Küpper and João Marcos Vilela Marcuz, positions itself as a 'no-FOMO, no-hype' investor, emphasizing concentrated portfolios and deep operational support over a spray-and-pray approach [Airborne Ventures, retrieved 2024]. Its wedge is a claimed track record of over 70 investments and significant exits from its partners' prior institutional roles, which it leverages to provide strategic guidance and network access to portfolio companies [Airborne Ventures, retrieved 2024].

Founding Partner Eduardo Küpper brings a background from Bradesco's venture arm, where he was responsible for funds totaling R$1.7 billion in assets under management and executed over 50 deals [Crunchbase, retrieved 2026]. This institutional experience forms the core of the firm's thesis, which is to apply rigorous, fundamentals-driven investing to the LatAm B2B landscape. The firm's business model is standard for a venture fund, raising capital from limited partners to make equity investments, though the size of its fund or specific check sizes are not publicly disclosed.

Over the next 12-18 months, the key indicators to watch will be the public disclosure of a named portfolio, which would allow for independent verification of deployment pace and quality, and any announcement of a formal fund close with named LPs, which would clarify the firm's scale and institutional backing. Data Accuracy: YELLOW -- Core firm description and team background corroborated by multiple sources; key performance and scale metrics are self-reported.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	B2B
Industry / Vertical	Fintech
Technology Type	Software (Non-AI)
Geography	Latin America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Company Overview

PUBLIC

Airborne Ventures was founded in 2021 as a São Paulo-based venture capital fund, positioning itself from the outset as a regionally focused, hands-on investor. The firm's public narrative centers on its founding partners' operational and investing experience, which it channels into a concentrated portfolio of early-stage B2B companies, with a stated emphasis on fintech and healthcare [Airborne Ventures, retrieved 2024]. The founding team, led by Eduardo Küpper, characterizes the fund as an "entrepreneur-turned-into-investor" vehicle, a framing intended to signal deep founder empathy and practical support [Crunchbase, retrieved 2026].

Key operational milestones are presented as aggregate track record claims rather than specific, dated fund closes or portfolio company launches. The firm states its team has experience across more than 70 investments, having participated in over 100 investment rounds and led more than 30 of those at Seed through Series B stages [Airborne Ventures, retrieved 2024]. It also claims its portfolio companies have collectively secured over $1 billion in follow-on funding, a metric used to signal the fund's ability to help startups progress to later financing rounds [Airborne Ventures, retrieved 2024].

A core part of the firm's identity is its declared investment philosophy. Airborne Ventures explicitly brands itself as a "no-FOMO, no-hype VC fund," a stance that critiques the spray-and-pray approach common in venture capital [Airborne Ventures, retrieved 2024]. This philosophy is operationalized through a focus on fundamentals and a promise of active, hands-on partnership, which the firm metaphorically describes as preparing companies to "go Airborne" in a stabilized manner [Airborne Ventures, retrieved 2024]. The firm also publicly aligns itself with the Mensarius Oath, a pledge for ethical investing [LinkedIn, retrieved 2026].

Data Accuracy: YELLOW -- Founding year and location are corroborated by Crunchbase. Numerous operational and track record claims are sourced solely from the company's own website and have not been independently verified by third-party publishers.

Product and Technology

MIXED

Airborne Ventures does not sell a software product; its product is the fund itself and the associated capital and services provided to portfolio companies. The firm’s stated offering is a blend of equity investment and active, hands-on operational support, targeting early-stage B2B startups in fintech and healthcare across Latin America [Airborne Ventures, 2024].

The firm’s operational support model is described in general terms on its website. It claims to act as a catalyst, channeling resources and expertise to help entrepreneurs scale faster and operate smarter [Airborne Ventures, 2024]. This includes anticipating roadblocks early and helping founders design practical, execution-ready solutions [Airborne Ventures, 2024]. The firm emphasizes being 'partners activos' (active partners) who accompany startups to scale, a position echoed in external ecosystem messaging [Airborne Ventures, 2024]. The investment thesis is built on the team's collective experience across more than 70 investments, which is leveraged to provide deep industry knowledge and network access [Airborne Ventures, 2024].

Specific check sizes, fund structures, or detailed service-level agreements are not publicly disclosed. The firm’s website does not list any proprietary technology, software platforms, or tools offered to founders, focusing instead on advisory and network-based support. The firm also publicly supports the Mensarius Oath, a pledge for ethical investing [LinkedIn, 2026].

Data Accuracy: YELLOW -- Core service description confirmed by company website; specific operational methods and claimed track record are not independently verified.

Market Research

PUBLIC The Brazilian and Latin American venture capital market has matured beyond a purely consumer-focused narrative, creating a structural opening for specialized funds targeting B2B software, particularly in fintech and healthcare.

Third-party market sizing for the specific niche of early-stage B2B fintech and healthcare venture capital in Latin America is not publicly available. However, broader regional data provides context. According to the Association for Private Capital Investment in Latin America (LAVCA), venture capital investment in Latin America reached $7.8 billion in 2021, a record high, before a market correction in 2022-2023 [LAVCA, 2022]. Within this, fintech has consistently been the leading sector by deal volume, representing 25% of all VC deals in the region in 2021 [LAVCA, 2022]. The healthcare and life sciences sector, while smaller, has shown accelerated growth, with investment increasing over 300% from 2019 to 2021 [LAVCA, 2022]. This data suggests a substantial and active market for venture capital, with established demand in the firm's stated focus areas.

Demand drivers for B2B solutions in these sectors are well-documented. In fintech, a persistent gap in financial inclusion and the modernization of legacy banking infrastructure creates demand for software addressing payments, credit, and back-office operations for businesses [World Bank, 2022]. For healthcare, the pandemic exposed systemic inefficiencies in Latin American health systems, accelerating digital transformation and investment in telehealth, hospital management software, and diagnostic tools [CB Insights, 2022]. A concurrent tailwind is the growing sophistication of enterprise buyers in the region, who are increasingly willing to adopt SaaS solutions to improve productivity and compliance.

Key adjacent markets that influence opportunity and risk include the broader Latin American private equity landscape and global venture capital. Large global funds have increased their allocation to Latin America, raising competition for top deals but also validating the region's potential [Bain & Company, 2023]. Substitute markets are less about direct competitors and more about alternative capital sources, such as corporate venture arms of major banks and insurers, which are active in both fintech and healthtech, and regional family offices increasingly deploying capital into technology.

Regulatory and macro forces present a mixed picture. Brazil's Central Bank has actively promoted open banking and instant payment systems (Pix), creating a regulatory-driven catalyst for fintech innovation [Banco Central do Brasil, 2021]. Conversely, political volatility in several LatAm countries and historically high interest rates have tightened capital availability and extended sales cycles for B2B startups, emphasizing the need for investors with operational patience and local market expertise.

Metric	Value
Latin America VC Investment (2021)	7.8 $B
Fintech Share of VC Deals (2021)	25 %
Healthcare VC Growth (2019-2021)	300 %

The chart underscores the scale of the regional venture market and the historical dominance of fintech, while the explosive growth percentage in healthcare signals a sector transitioning from niche to mainstream for investors.

Data Accuracy: YELLOW -- Market sizing figures are from a reputable industry association report, but they are regional and sector-level, not specific to the fund's precise early-stage B2B thesis.

Competitive Landscape

MIXED Airborne Ventures enters a Brazilian early-stage venture market defined by its density of generalist funds, requiring a clear articulation of its niche to stand apart.

The competitive analysis must be drawn from the broader market context and the firm's stated positioning.

Mapping the competitive field requires segmenting by investor type and focus. In the broad category of early-stage capital for Brazilian B2B startups, Airborne faces several established cohorts.

• Large, multi-stage Brazilian VCs. Firms like Monashees and Kaszek are dominant forces with extensive track records, large funds, and deep networks across Latin America. Their scale allows for larger checks and follow-on reserves, but their portfolios are broad and their partner time is necessarily divided.
• Specialist fintech and healthtech funds. While numerous global funds target these sectors, local specialists with dedicated sector expertise are less common in Brazil's early-stage scene. This is the white space Airborne explicitly targets, competing against the sector-focused teams within larger generalist firms.
• Corporate venture arms. Banks like Itaú (Itaú Ventures) and Bradesco (Inovabra, where founding partner Eduardo Küpper previously worked) are active, strategic investors. They offer potential commercial partnerships but may be perceived as slower or more operationally rigid than independent funds.
• Angel syndicates and micro-VCs. A growing number of operator-led angel groups and small funds provide seed capital. They often compete on speed and founder affinity but lack the institutional support and follow-on capacity Airborne claims to offer.

Airborne's stated defensible edge rests on two pillars: a concentrated, hands-on portfolio model and the founding partner's prior institutional experience. The 'no-FOMO, no-hype' positioning is a direct critique of the spray-and-pray approach attributed to some funds chasing hype cycles [Airborne Ventures, 2024]. The claim of being 'partners activos' suggests a higher-touch, operational support model than a purely financial investor. The edge is theoretically durable if it translates into superior portfolio company outcomes and founder testimonials, which can attract a proprietary deal flow. However, it is perishable if the firm cannot demonstrate this support with concrete portfolio successes or if key partners become spread too thin as the fund scales.

The firm's most significant exposure is its lack of a publicly demonstrable track record under its own brand. While the founding partner cites a personal history of $200M+ exits and 9.5x+ MOIC [LinkedIn, 2026], these are attributed to his prior role, not Airborne's fund performance. In a market where founders increasingly scrutinize a fund's specific portfolio and references, the absence of named portfolio companies is a material disadvantage against incumbents with long lists of branded investments. Furthermore, the focus on two of the most competitive sectors (fintech and healthtech) means Airborne is competing for deals against the very largest and most well-resourced funds in the region, which can outbid on price or offer more certain follow-on funding.

The most plausible 18-month scenario hinges on proof of execution. If Airborne can close and announce its first fund, publicly name a cohort of seed-stage investments, and begin generating portfolio-level traction, it will solidify its position as a credible specialist. A 'winner' in this case would be a firm like Kaszek, which continues to benefit from market consolidation and its ability to write larger checks across stages, further marginalizing newer, smaller entrants. A 'loser' would be the broader category of undifferentiated micro-VCs and angel syndicates, which may struggle to compete for allocation in top deals if specialized, institutional-quality seed funds like Airborne gain traction and demonstrate they offer both capital and superior strategic value.

Data Accuracy: YELLOW -- Competitive mapping is inferred from the firm's stated focus and the general LatAm VC landscape, as no specific competitors are named in available sources.

Opportunity

PUBLIC The prize for a venture fund that successfully identifies and scales the next generation of B2B fintech and healthcare leaders in Latin America is a portfolio capable of generating billions in enterprise value, anchored by a handful of category-defining companies.

The headline opportunity for Airborne Ventures is to become the definitive early-stage capital partner for Brazil's emerging B2B infrastructure layer. The region's financial and healthcare systems are undergoing a foundational rebuild, shifting from legacy, in-house solutions to modular, API-driven services. A fund that consistently picks winners in this transition,companies that become the embedded plumbing for entire sectors,could achieve outlier returns. The plausibility of this outcome rests on the firm's stated, concentrated approach to fundamentals over hype [Airborne Ventures, retrieved 2024] and the founding partner's documented experience overseeing a significant venture portfolio within Brazil's largest private bank [Crunchbase, retrieved 2026]. This background suggests a network and pattern recognition tuned to the specific challenges of scaling B2B solutions in a complex regulatory environment, which is the critical wedge for building a category-defining portfolio.

Growth would likely follow one of several concrete paths, each with identifiable catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Thematic Fund Dominance	Airborne becomes the first name founders in Brazilian fintech or healthtech seek for Seed capital, building a proprietary deal flow that bypasses broader market auctions.	A flagship portfolio company achieves a landmark exit (e.g., a $500M+ acquisition by a global incumbent), validating the firm's selection thesis and operational support model.	The firm's thesis is explicitly built around deep sector focus in fintech and healthcare [Perplexity Sonar Pro Brief, retrieved 2024], and the team claims experience across 70+ investments [Airborne Ventures, retrieved 2024], providing a base of pattern recognition.
Strategic LP Anchor	The fund secures a cornerstone commitment from a major Brazilian pension fund or corporate venture arm, providing larger, follow-on capital to double down on winners and lead later rounds.	A change in local regulation or institutional investment policy increases the allocation mandate for early-stage venture within domestic asset pools.	The founding partner's prior role involved managing R$ 1.7 billion in AUM within the venture arm of a major bank [Crunchbase, retrieved 2026], demonstrating a track record of institutional capital stewardship in the region.

Compounding for a venture fund manifests in the quality and density of its network. An initial portfolio of high-caliber companies attracts ambitious founders, which in turn attracts co-investors seeking access to those deals, strengthening the fund's syndication power. This virtuous cycle can lead to preferential allocation in competitive rounds. Airborne's materials emphasize being "partners activos" and building a network with "major financial investors and hundreds of successful founders" [Airborne Ventures, retrieved 2024], indicating an intentional strategy to cultivate this flywheel from the outset. Each successful exit would recycle not just capital but also credibility and founder relationships back into the fund's core engine.

The size of the win can be framed by looking at the trajectory of comparable early-stage funds in emerging markets. For instance, a fund that successfully backs a single company reaching a $1 billion valuation,a plausible, though ambitious, outcome in the LatAm B2B fintech space,can generate a fund-returning outcome on that position alone if its initial stake is meaningful. A concentrated portfolio with multiple such outcomes could drive a fund-level TVPI (Total Value to Paid-In Capital) well into the upper quartile of global venture benchmarks. While specific fund sizes are not public, the founding partner's claimed personal track record of 9.5x+ MOIC [LinkedIn, retrieved 2026] sets an aspirational benchmark for the kind of performance that would define a top-tier outcome. If the firm's concentrated, hands-on model works as intended, it could plausibly achieve a fund valuation in the hundreds of millions of dollars based on the carried interest from a portfolio of scaled winners (scenario, not a forecast).

Data Accuracy: YELLOW -- Core opportunity thesis is inferred from the firm's stated focus and partner background; specific portfolio outcomes and fund performance metrics are not publicly verified.

Sources

PUBLIC

1. [Airborne Ventures, retrieved 2024] About - Airborne Ventures | https://www.airborne.ventures/about

2. [Airborne Ventures, retrieved 2024] Portfolio - Airborne Ventures | https://www.airborne.ventures/portfolio

3. [Airborne Ventures, retrieved 2024] Network - Airborne Ventures | https://www.airborne.ventures/network

4. [Airborne Ventures, retrieved 2024] Team - Airborne Ventures | https://www.airborne.ventures/team

5. [Airborne Ventures, retrieved 2024] FAQ - Airborne Ventures | https://www.airborne.ventures/faq

6. [Airborne Ventures, retrieved 2024] Why Outliers and Ownership Is Only Half the Story - Airborne Ventures | https://www.airborne.ventures/blog/https-edukpr-substack-com-p-debunking-the-vc-narrative-why-outliers

7. [Perplexity Sonar Pro Brief, retrieved 2024] Airborne Ventures Brief | https://www.airborne.ventures/

8. [Crunchbase, retrieved 2026] Airborne Ventures - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/airborne-ventures

9. [Crunchbase, retrieved 2026] Eduardo Kupper - Founding Partner @ Airborne Ventures - Crunchbase Person Profile | https://www.crunchbase.com/person/eduardo-gomes-kupper

10. [LinkedIn, retrieved 2026] Eduardo Küpper - GP @ Airborne Ventures | https://br.linkedin.com/in/eduardokupper

11. [LAVCA, 2022] LAVCA 2022 Latin American Venture Capital Report | https://lavca.org/research/

12. [World Bank, 2022] Global Findex Database 2021 | https://www.worldbank.org/en/publication/globalfindex

13. [CB Insights, 2022] State Of Healthcare Q3'22: Report & Data | https://www.cbinsights.com/research/report/healthcare-trends-q3-2022/

14. [Bain & Company, 2023] Global Private Equity Report 2023 | https://www.bain.com/insights/topics/global-private-equity-report/

15. [Banco Central do Brasil, 2021] BCB - Open Banking | https://www.bcb.gov.br/en/financialstability/openbanking